Kornelia Karwowska

Ebola virus disease

K. Karwowska, H. D. Clerck, J. Griensven, 2019, The Lancet.

Real‐world effectiveness and safety of ombitasvir/paritaprevir/ritonavir ± dasabuvir ± ribavirin in hepatitis C: AMBER study

K. Simon, A. Horban, E. Janczewska, 2016, Alimentary pharmacology & therapeutics.

Renal impairment in patients with chronic hepatitis C treated with first generation protease inhibitors

D. Dybowska, M. Wietlicka-Piszcz, D. Kozielewicz, 2015, Expert opinion on drug safety.